What smart money is saying about Alpha Teknova, Inc.
TKNO
No fund has written a full thesis on Alpha Teknova, Inc. in our archive, but 2 fund letters report a position in it — most recently Conestoga Capital Advisors Small Cap, SMid Cap & Micro Cap Strategies in September 2026.
Get an email when a fund buys, sells or pitches it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in Alpha Teknova, Inc. on record in the archive was reported in Q3 2026, across 2 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 0 | 0 |
Fund activity · 2 positions
- September 2026
“Another winner from our Biotech holdings was Alpha Teknova, Inc. (TKNO)”
Alpha Teknova, Inc. - September 2026
“2. Alpha Teknova (TKNO) TKNO manufactures customized reagents and other critical inputs used in life sciences research, diagnostics and biopharmaceutical development. 2Q revenue reached a company record as growth broadened across customers and end markets, while free cash outflow fell to its lowest level since before the company’s 2021 IPO.”
Alpha Teknova, Inc.
Read the letters behind these Alpha Teknova, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger